Skip to content
Search

Latest Stories

Glenmark Life Sciences is now Alivus Life Sciences

Glenmark Life Sciences is now Alivus Life Sciences
Glenmark Life Sciences is now Alivus Life Sciences

Nirma acquired a majority stake in Glenmark Life Sciences in March 2024, becoming the new promoter of the company 

Indian pharmaceutical company Glenmark Life Sciences (GLS) has rebranded as Alivus Life Sciences, following its acquisition by consumer goods holding conglomerate Nirma Limited.

It is a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas such as cardiovascular disease, central nervous system disease, pain management and diabetes.


In March 2024, Nirma Limited, headquartered in Ahmedabad, India, acquired a 75 per cent majority stake in Glenmark Life Sciences, becoming the new promoter of the company.

The pharmaceutical company has described the rebranding to Alivus Life Sciences as “an exciting new chapter” in its journey.

In a press release, the company explained: “The change is reflective of the company’s evolving vision aimed at further strengthening its global presence and a commitment to providing innovative solutions in the API and contract development and manufacturing organization (CDMO) space.

“The new identity, Alivus Life Sciences, represents vitality and growth with a renewed focus. It embodies the optimism and transformation the company is embracing as it enters the next phase of its journey.”

Along with the name change, the company’s official website is now alivus.com.

For the first half of FY25, Glenmark Life Sciences reported revenue from operations of Rs. 10,955 million (around £120 million), a 6.7 per cent year-on-year decrease. In Q2FY25, revenue from operations was reported at Rs. 5,069 million (approximately £53.22 million)

Dr. Yasir Rawjee, MD and CEO of Glenmark Life Sciences attributed the revenue decline to the temporary closure of the Ankleshwar facility, which delayed order fulfillment across geographies.

However, the loss of production has substantially been recovered and the company expects the second half of FY25 to outperform their earlier estimates.

Dr. Rawjee also highlighted that the company's product mix has led to improved gross margins of over 55 per cent.

“Looking ahead, we expect a strong second half of the fiscal year, supported by our solid order book. While overall growth for FY25 is projected to be in high single digits, we are confident in maintaining stable margins throughout the year,” he added.

Alivus Life Sciences provides CDMO services to a range of multinational and specialty pharmaceutical companies and has a portfolio of 161 molecules. The company supplies its products across India, Europe, North America, Latin America, Japan, and the rest of the world.

The company operates four manufacturing facilities, which are regularly inspected by global regulators such as USFDA, PMDA (Japan) and EDQM (Europe).

More For You

MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
Pharmacies in Northern Ireland distribute free booklets to raise cancer awareness

Dr Anna Cullen, Public Health Registrar at the Public Health Agency and Clare Conroy, Community Pharmacist from Meigh Pharmacy in Co Down.

Photo credit: Community Pharmacy Northern Ireland

Pharmacies in Northern Ireland help raise cancer awareness

Community pharmacies across Northern Ireland are distributing a free information booklet to help raise public awareness of the signs and symptoms of cancer and promote early diagnosis.

The initiative is part of the ‘Be Cancer Aware’ campaign, which has been running in pharmacies since April and will continue through May as part of the Living Well service.

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less
Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less